Table 1. Description of Patient Groups.

Characteristic	AMX Group	AZM Group
Number of Patients	7	6
Age*	51.0 ± 5.7	62.0 ± 4.1
Gender (M/F)†	3/4	4/2
Implant Location (mand/max)†	5/2	4/2
Implant placement	Bone level (7)	Bone level (6)
Acetaminophen tablets taken*	1.5 ± 0.85	1.8 ± 1.1
GI, day 0‡	0.00 (0.00, 0.00)	1.25 (0.00, 1.50)
PI, day 0‡	1.00 (1.00, 1.375)	1.00 (0.00, 1.00)
PI, day 20‡	0.00 (0.00, 0.875)	0.75 (0.00. 1.00)
mPI, day 6‡	0.00 (0.00, 0.375)	0.00 (0.00, 0.00)
mPI, day 20‡	0.00 (0.00, 0.00)	0.00 (0.00, 0.00)
Implant failures (24 months)	0/7	0/6

^*Presented as mean ± SEM. Difference between groups is not statistically significant (P>0.05, t-test)

^†Proportions not significantly different from that expected from random occurrence (P>0.05, Fisher Exact test)

^‡Presented as median (25%, 75%). Difference between groups is not statistically significant (P>0.05, Mann-Whitney rank sum test)